Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.39 |
| ▸ | TSHR | P16473 | 4/20 | 0.35 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.35 |
| ▸ | CHRM2 | P08172 | 3/20 | 0.35 |
| ▸ | CHRM1 | P11229 | 3/20 | 0.35 |
| ▸ | HTR1A | P08908 | 1/20 | 0.35 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.35 |
| ▸ | DRD1 | P21728 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.35 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5469999 | 0.95 | L3MBTL1 (0.40) | L3MBTL1TSHRCYP3A4CHRM2CHRM1 | |
| SCHEMBL5455660 | 0.91 | L3MBTL1 (0.39) | L3MBTL1TSHRCYP3A4CHRM2CHRM1 | |
| SCHEMBL5456461 | 0.91 | L3MBTL1 (0.45) | L3MBTL1TSHRCYP3A4CHRM2CHRM1 | |
| SCHEMBL5461306 | 0.91 | EPHX2 (0.37) | L3MBTL1CHRM2CHRM1HTR1AADRA2A | |
| SCHEMBL5406520 | 0.87 | L3MBTL1 (0.38) | L3MBTL1TSHRCYP3A4CHRM2CHRM1 | |
| SCHEMBL5467951 | 0.86 | EPHX2 (0.38) | L3MBTL1TSHRCYP3A4CHRM2CHRM1 | |
| SCHEMBL5324822 | 0.86 | L3MBTL1 (0.41) | L3MBTL1TSHRCYP3A4CHRM2CHRM1 | |
| SCHEMBL5463665 | 0.83 | TSHR (0.38) | L3MBTL1TSHRCYP3A4ALDH1A1MAPK1 | |
| SCHEMBL5462091 | 0.83 | TSHR (0.31) | TSHR | |
| SCHEMBL5456436 | 0.82 | L3MBTL1 (0.43) | L3MBTL1TSHRLMNAKMT2AEPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070281996-A1 | Creatine prodrugs, compositions and uses thereof | XENOPORT, INC. | 2007-12-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070281996-A1 | Creatine prodrugs, compositions and uses thereof | CKMT1A; CKMT1B, PYGM, TNNI3 | L3MBTL1 2963/4885TSHR 3387/4885CYP3A4 1193/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.